专题：Neutropenia and Cancer Infections

This cluster of papers focuses on the management of febrile neutropenia in cancer patients, particularly those with hematological malignancies receiving chemotherapy. It includes clinical practice guidelines, updates on antimicrobial agents, use of granulocyte colony-stimulating factor, risk assessment tools, prophylactic strategies, and the impact of febrile neutropenia on morbidity and mortality.
最新文献
In Regard to Grippin et al

letter Full Text OpenAlex

In Regard to Moreno et al

letter Full Text OpenAlex

Tackling antimicrobial resistance in people who are immunocompromised: leveraging diagnostic and antimicrobial stewardship

review Full Text OpenAlex

Successful treatment of refractory cancer therapy-induced thrombocytopenia in a breast cancer patient using romiplostim N01: A case report.

article Full Text OpenAlex

[Interventional management of gastrointestinal and uterine bleeding in a patient with acute myeloid leukemia on induction therapy: case report].

article Full Text OpenAlex

Objectively measured physical function predicts mortality in older adults with acute myeloid leukemia treated by lower-intensity therapy: A prospective cohort study

article Full Text OpenAlex

Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs

article Full Text OpenAlex

False Positive Peripheral Blood Cultures in Children with Leukaemia: A Descriptive Retrospective Prevalence Study

article Full Text OpenAlex

Diagnostic and Prognostic Utility of Serum Presepsin, CRP, and Procalcitonin in Pediatric Febrile Neutropenia

preprint Full Text OpenAlex

Cutaneous tuberculosis revealing disseminated infection in a young patient with myelodysplastic syndrome: A case report

article Full Text OpenAlex

近5年高被引文献
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

article Full Text OpenAlex 627 FWCI50.939

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer

article Full Text OpenAlex 256 FWCI35.594

Sepsis-Induced Immunosuppression

review Full Text OpenAlex 235 FWCI8.172

De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017

article Full Text OpenAlex 196 FWCI26.475

8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation

review Full Text OpenAlex 176 FWCI4.404

CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial

article Full Text OpenAlex 158 FWCI22.295

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

review Full Text OpenAlex 152 FWCI4.355

The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

review Full Text OpenAlex 150 FWCI6.302

Estimation of the Number of Individuals Living With Metastatic Cancer in the United States

article Full Text OpenAlex 132 FWCI18.221

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

article Full Text OpenAlex 124 FWCI47.789